These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 861646)

  • 1. Antipyrine, paracetamol, and lignocaine elimination in chronic liver disease.
    Forrest JA; Finlayson ND; Adjepon-Yamoah KK; Prescott LF
    Br Med J; 1977 May; 1(6073):1384-7. PubMed ID: 861646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paracetamol (acetaminophen) clearance in patients with cirrhosis of the liver.
    Andreasen PB; Hutters L
    Acta Med Scand Suppl; 1979; 624():99-105. PubMed ID: 284720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clearance of antipyrine and indocyanine green in normal subjects and in patients with chronic lever disease.
    Branch RA; James JA; Read AE
    Clin Pharmacol Ther; 1976 Jul; 20(1):81-9. PubMed ID: 1277728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of serum antipyrine half-lives in patients with liver disease.
    Branch RA; Herbert CM; Read AE
    Gut; 1973 Jul; 14(7):569-73. PubMed ID: 4729926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antipyrine and lidocaine are cleared faster in horses than in humans: acetaminophen may be handled similarly.
    Engelking LR; Lofstedt J; Blyden GT; Greenblatt DJ
    Pharmacology; 1987; 34(4):192-200. PubMed ID: 3602088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal drug metabolism after barbiturate and paracetamol overdose.
    Forrest JA; Roscoe P; Prescott LF; Stevenson IH
    Br Med J; 1974 Nov; 4(5943):499-502. PubMed ID: 4434117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proceedings: Antipyrine, lingocaine and paracetamol metabolism in chronic liver disease.
    Forrest JA; Finlayson ND; Adjepon-Yamoah KK; Prescott LF
    Gut; 1975 Oct; 16(10):828-9. PubMed ID: 1205294
    [No Abstract]   [Full Text] [Related]  

  • 8. Impaired Lignocaine metabolism in patients with myocardial infarction and cardiac failure.
    Prescott LF; Adjepon-Yamoah KK; Talbot RG
    Br Med J; 1976 Apr; 1(6015):939-41. PubMed ID: 1268491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paracetamol metabolism in chronic liver disease.
    Forrest JA; Adriaenssens P; Finlayson ND; Prescott LF
    Eur J Clin Pharmacol; 1979 Jul; 15(6):427-31. PubMed ID: 499292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gross impairment of hepatic drug metabolism in a patient with chronic liver disease.
    Adjepon-Yamoah KK; Nimmo J; Prescott LF
    Br Med J; 1974 Nov; 4(5941):387-8. PubMed ID: 4425889
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of acute and chronic propranolol administration on antipyrine and paracetamol clearance in patients with chronic liver disease.
    Hayes PC; Bouchier IA
    Am J Gastroenterol; 1989 Jul; 84(7):723-6. PubMed ID: 2741882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition of four drugs in malnourished children.
    Mehta S; Nain CK; Sharma B; Mathur VS
    Drug Nutr Interact; 1982; 1(3):205-11. PubMed ID: 6821389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salivary antipyrine kinetics in hepatic and renal disease and in patients on anticonvulsant therapy.
    Harman AW; Penhall RK; Priestly BG; Frewin DB; Phillips PJ; Clarkson AR
    Aust N Z J Med; 1977 Aug; 7(4):385-90. PubMed ID: 270989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipyrine metabolism and liver function in patients treated with high-dose medroxyprogesterone.
    Rautio A; Kauppila AJ; Tuimala RJ; Sotaniemi EA
    Biomedicine; 1979 Sep; 31(5):135-8. PubMed ID: 508896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug metabolism in liver disease.
    Prescott LF; Forrest JA; Adjepon-Yamoah KK; Finlayson ND
    J Clin Pathol Suppl (R Coll Pathol); 1975; 9():62-5. PubMed ID: 783214
    [No Abstract]   [Full Text] [Related]  

  • 16. Impairment of drug elimination in patients with liver disease.
    Narang AP; Datta DV; Mathur VS
    Int J Clin Pharmacol Ther Toxicol; 1985 Jan; 23(1):28-32. PubMed ID: 3988389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antipyrine elimination as a dynamic test of hepatic functional integrity in obstructive jaundice.
    McPherson GA; Benjamin IS; Boobis AR; Brodie MJ; Hampden C; Blumgart LH
    Gut; 1982 Sep; 23(9):734-8. PubMed ID: 7106619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk prediction of hepatotoxicity in paracetamol poisoning.
    Wong A; Graudins A
    Clin Toxicol (Phila); 2017 Sep; 55(8):879-892. PubMed ID: 28447858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered elimination of antipyrine in patients with acute viral hepatitis.
    Burnett DA; Barak AJ; Tuma DJ; Sorrell MF
    Gut; 1976 May; 17(5):341-4. PubMed ID: 1278717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of antipyrine and lignocaine disposition in normal subjects and in patients treated with enzyme-inducing drugs.
    Perucca E; Hedges A; Makki KA; Richens A
    Br J Clin Pharmacol; 1980 Nov; 10(5):491-7. PubMed ID: 7437261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.